143 related articles for article (PubMed ID: 7173299)
1. Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.
Folgering HT; Borm JF; van Haaren RH
Eur J Clin Pharmacol; 1982 Oct; 23(4):283-8. PubMed ID: 7173299
[TBL] [Abstract][Full Text] [Related]
2. Exercise metabolism in healthy volunteers taking atenolol, high and low doses of metoprolol CR/Z0K, and placebo.
Head A; Maxwell S; Kendall MJ; Eagles C
Br J Clin Pharmacol; 1994 Dec; 38(6):499-504. PubMed ID: 7888287
[TBL] [Abstract][Full Text] [Related]
3. Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.
Folgering H; van Bussel M
Eur J Clin Pharmacol; 1980 Oct; 18(3):225-9. PubMed ID: 7439241
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.
Freestone S; Silas JH; Lennard MS; Ramsay LE
Br J Clin Pharmacol; 1982 Nov; 14(5):713-8. PubMed ID: 7138751
[TBL] [Abstract][Full Text] [Related]
5. Effects of a week's beta-adrenoceptor blockade with atenolol and metoprolol CR/ZOK on the response to exercise in healthy women aged 50 to 70 years.
Patrick J; Bassey J; Morrant J; Macdonald I
J Clin Pharmacol; 1990 Feb; 30(S2):S108-16. PubMed ID: 2312773
[TBL] [Abstract][Full Text] [Related]
6. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
Houtzagers JJ; Streurman O; Regårdh CG
Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
[TBL] [Abstract][Full Text] [Related]
7. The comparative beta-adrenoceptor blocking effects of penbutolol, atenolol and sustained-release metoprolol in healthy volunteers.
Mucklow JC; Kuhn S
Eur J Clin Pharmacol; 1984; 27(3):269-73. PubMed ID: 6510453
[TBL] [Abstract][Full Text] [Related]
8. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
Eagles CJ; Kendall MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
[TBL] [Abstract][Full Text] [Related]
9. Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
Löfdahl CG; Dahlöf C; Westergren G; Olofsson B; Svedmyr N
Eur J Clin Pharmacol; 1988; 33 Suppl():S25-32. PubMed ID: 2836204
[TBL] [Abstract][Full Text] [Related]
10. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
[TBL] [Abstract][Full Text] [Related]
11. Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema.
Butland RJ; Pang JA; Geddes DM
J Appl Physiol Respir Environ Exerc Physiol; 1983 May; 54(5):1368-73. PubMed ID: 6863097
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenoceptor blockade and CNS-related subjective symptoms: a randomized, double-blind, placebo-controlled comparison of metoprolol CR/ZOK, atenolol and propranolol LA in healthy subjects.
Dimenäs E; Kerr D; Macdonald I
J Clin Pharmacol; 1990 Feb; 30(S2):S103-7. PubMed ID: 1968912
[TBL] [Abstract][Full Text] [Related]
14. Effects on exercise tachycardia during forty-eight hours of a series of doses of atenolol, sotalol, and metoprolol.
Harron DW; Balnave K; Kinney CD; Wilson R; Russell CJ; Shanks RG
Clin Pharmacol Ther; 1981 Mar; 29(3):295-302. PubMed ID: 7471600
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
Floras JS; Jones JV; Hassan MO; Sleight P
Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
[TBL] [Abstract][Full Text] [Related]
16. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
Nilsson OR; Atterhög JH; Castenfors J; Jorfelt L; Karlberg BE; Thulin T; Tolagen K; Wettre S; Ohman KP
Acta Med Scand; 1984; 216(3):301-7. PubMed ID: 6388253
[TBL] [Abstract][Full Text] [Related]
17. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE
Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545
[TBL] [Abstract][Full Text] [Related]
18. A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension.
Morley CA; Cavalcanti C; Perrins EJ; Sutton R
Br J Clin Pharmacol; 1983 Jun; 15(6):715-7. PubMed ID: 6347229
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.
McLeod AA; Brown JE; Kuhn C; Kitchell BB; Sedor FA; Williams RS; Shand DG
Circulation; 1983 May; 67(5):1076-84. PubMed ID: 6299612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
